High expression of mTOR (mammalian target of rapamycin) is associated with better outcome in non-small cell lung cancer

被引：0
|
作者：
Anagnostou, Valsamo
Bepler, Gerold
Syrigos, Konstantinos
Tanoue, Lynn
Gettinger, Scott
Homer, Robert
Boffa, Daniel
Detterbeck, Frank
Rimm, David
机构：
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Div Thorac Oncol, Tampa, FL 33682 USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Med Oncol,Yale Canc Ctr, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA
[5] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3842
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High Expression of Mammalian Target of Rapamycin Is Associated with Better Outcome for Patients with Early Stage Lung Adenocarcinoma
    Anagnostou, Valsamo K.
    Bepler, Gerold
    Syrigos, Konstantinos N.
    Tanoue, Lynn
    Gettinger, Scott
    Homer, Robert J.
    Boffa, Daniel
    Detterbeck, Frank
    Rimm, David L.
    CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4157 - 4164
  • [2] OVER-EXPRESSION OF THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR): A NOVEL BIOMARKER FOR POOR SURVIVAL IN RESECTED EARLY STAGE NON-SMALL CELL LUNG CANCER
    Dhillon, T.
    Seckl, M.
    Mauri, F.
    Belleza, G.
    North, B.
    Cagini, L.
    Barbareschi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S70 - S70
  • [3] Over-expression of the mammalian target of rapamycin (mTOR): a novel biomarker for poor survival in resected early stage non-small cell lung cancer
    Dhillon, Tony
    Mauri, Francesco
    Bellezza, Guido
    Cagini, Lucio
    North, Bernard
    Barbareschi, Mattia
    Seckl, Michael
    CANCER RESEARCH, 2009, 69
  • [4] Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway
    Zhang, Wenhua
    Shao, Xueqian
    MEDICAL SCIENCE MONITOR, 2016, 22 : 4644 - 4650
  • [5] Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression
    Kim, Young-Sun
    Jin, Hyeon-Ok
    Seo, Sung-Keum
    Woo, Sang Hyeok
    Choe, Tae-Boo
    An, Sungkwan
    Hong, Seok-Il
    Lee, Su-Jae
    Lee, Kee-Ho
    Park, In-Chul
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (03) : 216 - 226
  • [6] Targeting the Phosphatidylinosital 3-Kinase, Akt, and Mammalian Target of Rapamycin Pathway in Non-small Cell Lung Cancer
    Cuffe, Sinead
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : S1805 - S1807
  • [7] Immunohistochemical evaluation of the mammalian target of rapamycin pathway in stage I non-small cell lung carcinoma
    Kim, H. R.
    Choi, C. M.
    Lee, J. C.
    Shin, E.
    Park, Y. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S148 - S148
  • [8] Chnicopathologic Implication of mTOR/pAKT Expression in Non-Small Cell Lung Cancer
    Oh, Mee-Hye
    Choi, Jae Sung
    Kim, Yong Hoon
    Lee, Seok Yeol
    Sung, Sook Whan
    Lee, Choon-Taek
    Jheon, Sanghoon
    Chung, Jin Haeng
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S406 - S406
  • [9] Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer
    Oh, Mee-Hye
    Lee, Hyun Ju
    Yoo, Seol Bong
    Xu, Xianhua
    Choi, Jae Sung
    Kim, Yong Hoon
    Lee, Seok Yeol
    Lee, Choon-Taek
    Jheon, Sanghoon
    Chung, Jin-Haeng
    VIRCHOWS ARCHIV, 2012, 460 (06) : 601 - 609
  • [10] Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer
    Kim, H. -J.
    Oh, M. -H.
    Lee, H. -J.
    Yoo, S. -B.
    Xu, X.
    Choi, J. -S.
    Kim, Y. -H.
    Lee, S. -Y.
    Lee, C. -T.
    Jheon, S. -H.
    Chung, J. -H.
    VIRCHOWS ARCHIV, 2012, 461 : S65 - S65
12345